Additionally, the study revealed that ALDH1A1 overexpression is associated with high expression of Polo-like kinase 3 (PLK3) in prostate cancer bone metastases, suggesting that ALDH1A1 regulates PLK3 through its interplay with AR and RAR-dependent transcription. Here, RARA is linked to prostate carcinoma.